Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia.

Bibliographical data

Original languageGerman
Article number1
ISSN0001-5792
Publication statusPublished - 2009
pubmed 19602874